Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/132407
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | National predictors of influenza vaccine uptake in pregnancy: the FluMum prospective cohort study, Australia, 2012–2015 |
Author: | McHugh, L. O'Grady, K.A.F. Nolan, T. Richmond, P.C. Wood, N. Marshall, H.S. Lambert, S.B. Chatfield, M.D. Perrett, K.P. Binks, P. Binks, M.J. Andrews, R.M. |
Citation: | Australian and New Zealand Journal of Public Health, 2021; 45(5):455-461 |
Publisher: | Wiley |
Issue Date: | 2021 |
ISSN: | 1326-0200 1753-6405 |
Statement of Responsibility: | Lisa McHugh, Kerry-Ann F. O’Grady, Terry Nolan, Peter C. Richmond, Nicholas Wood, Helen S. Marshall, Stephen B. Lambert, Mark D. Chatfield, Kirsten P. Perrett, Paula Binks, Michael J. Binks, Ross M. Andrews |
Abstract: | Objective: Ascertain predictors of inactivated influenza vaccine (IIV) uptake in pregnancy in mother–infant pairs from six Australian sites over four consecutive influenza seasons (2012–2015). Methods: Prospective observational cohort study calculating proportions of unvaccinated and vaccinated pregnancies. Multivariable logistic regression calculating adjusted odds ratios (aOR) and 95% confidence intervals (95%CI) to determine demographic, pregnancy and birth characteristics as predictors of IIV uptake in pregnancy. Results: Uptake of IIV was 36% (n=3,651/9,878) with only 3–4% during the first trimester. Validation of IIV receipt was obtained for 77% of vaccinated participants. Predictors of IIV uptake in pregnancy were: healthcare provider recommendation to have IIV during pregnancy (aOR 7.04 [95%CI 5.83-8.50]): GP (aOR 4.12 [95%CI 3.43-4.98]), obstetrician (aOR 4.41 [95%CI 3.45-5.64]), midwife (aOR 1.88 [95%CI 1.51-2.36]); previous IIV within 12 months of their current pregnancy (aOR 2.87 [95%CI 2.36-3.50]); and pertussis vaccination during the current pregnancy (aOR 4.88 [95%CI 4.08-5.83]). Conclusions and implications for public health: Healthcare provider discussions with pregnant women about the risks associated with influenza infection during pregnancy and early infancy and evidence about the safety and effectiveness of IIV are required. Recommending and offering IIV in pregnancy needs to be included in these discussions to improve uptake. |
Keywords: | Influenza; vaccination; pregnancy; predictors |
Rights: | © 2021 The Authors This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
DOI: | 10.1111/1753-6405.13130 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/1020035 http://purl.org/au-research/grants/nhmrc/1116530 http://purl.org/au-research/grants/nhmrc/490338 http://purl.org/au-research/grants/nhmrc/1045157 http://purl.org/au-research/grants/nhmrc/GNT1155066 http://purl.org/au-research/grants/nhmrc/1142783 http://purl.org/au-research/grants/nhmrc/1190983 http://purl.org/au-research/grants/nhmrc/GNT131932 |
Published version: | http://dx.doi.org/10.1111/1753-6405.13130 |
Appears in Collections: | Paediatrics publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_132407.pdf | Published version | 610.67 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.